Opinion|Videos|January 1, 2025

Discussing Seladelpar as a Potential Therapeutic for PBC

Panelists discuss how seladelpar showed remarkable efficacy in the RESPONSE trial, demonstrating significant improvements in alkaline phosphatase levels and other biochemical markers compared with placebo.

Video content above is prompted by the following:

  1. Seladelpar has been studied extensively, with the RESPONSE trial serving as one of its landmark studies. What are the key efficacy findings from this trial?

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME